
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Plasma interleukin-22 concentration and disease activity in inflammatory bowel disease - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="D2E4B91C8AF3F82305B91C003FE7063D.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="scirep">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12365130/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Scientific Reports">
<meta name="citation_title" content="Plasma interleukin-22 concentration and disease activity in inflammatory bowel disease">
<meta name="citation_author" content="Claudia Cabrera">
<meta name="citation_author_institution" content="BioPharmaceutical Medical, Real World Science &amp; Analytics, AstraZeneca, Pepparedsleden 1, 431 83 Gothenburg, Sweden">
<meta name="citation_author" content="Daniel Fernández-Llaneza">
<meta name="citation_author_institution" content="BioPharmaceutical Medical, Real World Science &amp; Analytics, AstraZeneca, Cambridge, UK">
<meta name="citation_author_institution" content="Present Address: Amsterdam UMC, Amsterdam, Netherlands">
<meta name="citation_author" content="Marita Olsson">
<meta name="citation_author_institution" content="Biometrics and Statistical Innovation, Late-Stage Development Respiratory &amp; Immunology, AstraZeneca, Gothenburg, Sweden">
<meta name="citation_author" content="Charles Sopp">
<meta name="citation_author_institution" content="BioPharmaceutical Medical, Real World Science &amp; Analytics, AstraZeneca, Cambridge, UK">
<meta name="citation_author" content="Tara Fehlmann">
<meta name="citation_author_institution" content="Crohn’s &amp; Colitis Foundation, New York, NY USA">
<meta name="citation_author" content="Elizabeth A Duncan">
<meta name="citation_author_institution" content="Late Respiratory and Immunology (R&amp;I), BioPharmaceuticals R&amp;D, AstraZeneca, Durham, NC USA">
<meta name="citation_author_institution" content="Present Address: GSK, Durham, NC USA">
<meta name="citation_author" content="Emon Khan">
<meta name="citation_author_institution" content="Late Respiratory and Immunology (R&amp;I), BioPharmaceuticals R&amp;D, AstraZeneca, Cambridge, UK">
<meta name="citation_author" content="Junmei Cairns">
<meta name="citation_author_institution" content="Translational Science &amp; Experimental Medicine, Research and Early Development, Respiratory and Immunology (R&amp;I), BioPharmaceuticals R&amp;D, AstraZeneca, Gothenburg, Sweden">
<meta name="citation_author" content="Jessica Neisen">
<meta name="citation_author_institution" content="Translational Science &amp; Experimental Medicine, Research and Early Development, Respiratory and Immunology (R&amp;I), BioPharmaceuticals R&amp;D, AstraZeneca, Cambridge, UK">
<meta name="citation_author" content="Ulf Gehrmann">
<meta name="citation_author_institution" content="Translational Science &amp; Experimental Medicine, Research and Early Development, Respiratory and Immunology (R&amp;I), BioPharmaceuticals R&amp;D, AstraZeneca, Gothenburg, Sweden">
<meta name="citation_author_institution" content="Present Address: Biomedical Research, Novartis, Basel, Switzerland">
<meta name="citation_author" content="Nick Powell">
<meta name="citation_author_institution" content="Faculty of Medicine, Imperial College London, London, UK">
<meta name="citation_publication_date" content="2025 Aug 19">
<meta name="citation_volume" content="15">
<meta name="citation_firstpage" content="30399">
<meta name="citation_doi" content="10.1038/s41598-025-01939-7">
<meta name="citation_pmid" content="40830140">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12365130/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12365130/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12365130/pdf/41598_2025_Article_1939.pdf">
<meta name="description" content="The relationship between interleukin-22 and clinical characteristics of patients with inflammatory bowel disease is uncertain. We sought to determine whether plasma interleukin-22 concentrations are associated with disease activity in a large ...">
<meta name="og:title" content="Plasma interleukin-22 concentration and disease activity in inflammatory bowel disease">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="The relationship between interleukin-22 and clinical characteristics of patients with inflammatory bowel disease is uncertain. We sought to determine whether plasma interleukin-22 concentrations are associated with disease activity in a large ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12365130/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12365130">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1038/s41598-025-01939-7"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/41598_2025_Article_1939.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12365130%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12365130/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12365130/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12365130/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-scirep.jpg" alt="Scientific Reports logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Scientific Reports" title="Link to Scientific Reports" shape="default" href="http://www.nature.com/srep" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Sci Rep</button></div>. 2025 Aug 19;15:30399. doi: <a href="https://doi.org/10.1038/s41598-025-01939-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1038/s41598-025-01939-7</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22Sci%20Rep%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Sci%20Rep%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Sci%20Rep%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Sci%20Rep%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Plasma interleukin-22 concentration and disease activity in inflammatory bowel disease</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Cabrera%20C%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Claudia Cabrera</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Claudia Cabrera</span></h3>
<div class="p">
<sup>1</sup>BioPharmaceutical Medical, Real World Science &amp; Analytics, AstraZeneca, Pepparedsleden 1, 431 83 Gothenburg, Sweden </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Cabrera%20C%22%5BAuthor%5D" class="usa-link"><span class="name western">Claudia Cabrera</span></a>
</div>
</div>
<sup>1,</sup><sup>✉</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Fern%C3%A1ndez-Llaneza%20D%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Daniel Fernández-Llaneza</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Daniel Fernández-Llaneza</span></h3>
<div class="p">
<sup>2</sup>BioPharmaceutical Medical, Real World Science &amp; Analytics, AstraZeneca, Cambridge, UK </div>
<div class="p">
<sup>10</sup>Present Address: Amsterdam UMC, Amsterdam, Netherlands </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Fern%C3%A1ndez-Llaneza%20D%22%5BAuthor%5D" class="usa-link"><span class="name western">Daniel Fernández-Llaneza</span></a>
</div>
</div>
<sup>2,</sup><sup>10</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Olsson%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Marita Olsson</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Marita Olsson</span></h3>
<div class="p">
<sup>3</sup>Biometrics and Statistical Innovation, Late-Stage Development Respiratory &amp; Immunology, AstraZeneca, Gothenburg, Sweden </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Olsson%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Marita Olsson</span></a>
</div>
</div>
<sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Sopp%20C%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Charles Sopp</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Charles Sopp</span></h3>
<div class="p">
<sup>2</sup>BioPharmaceutical Medical, Real World Science &amp; Analytics, AstraZeneca, Cambridge, UK </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Sopp%20C%22%5BAuthor%5D" class="usa-link"><span class="name western">Charles Sopp</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Fehlmann%20T%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Tara Fehlmann</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Tara Fehlmann</span></h3>
<div class="p">
<sup>4</sup>Crohn’s &amp; Colitis Foundation, New York, NY USA </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Fehlmann%20T%22%5BAuthor%5D" class="usa-link"><span class="name western">Tara Fehlmann</span></a>
</div>
</div>
<sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Duncan%20EA%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Elizabeth A Duncan</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Elizabeth A Duncan</span></h3>
<div class="p">
<sup>5</sup>Late Respiratory and Immunology (R&amp;I), BioPharmaceuticals R&amp;D, AstraZeneca, Durham, NC USA </div>
<div class="p">
<sup>11</sup>Present Address: GSK, Durham, NC USA </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Duncan%20EA%22%5BAuthor%5D" class="usa-link"><span class="name western">Elizabeth A Duncan</span></a>
</div>
</div>
<sup>5,</sup><sup>11</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Khan%20E%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Emon Khan</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Emon Khan</span></h3>
<div class="p">
<sup>6</sup>Late Respiratory and Immunology (R&amp;I), BioPharmaceuticals R&amp;D, AstraZeneca, Cambridge, UK </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Khan%20E%22%5BAuthor%5D" class="usa-link"><span class="name western">Emon Khan</span></a>
</div>
</div>
<sup>6</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Cairns%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Junmei Cairns</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">Junmei Cairns</span></h3>
<div class="p">
<sup>7</sup>Translational Science &amp; Experimental Medicine, Research and Early Development, Respiratory and Immunology (R&amp;I), BioPharmaceuticals R&amp;D, AstraZeneca, Gothenburg, Sweden </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Cairns%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Junmei Cairns</span></a>
</div>
</div>
<sup>7</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Neisen%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id9"><span class="name western">Jessica Neisen</span></a><div hidden="hidden" id="id9">
<h3><span class="name western">Jessica Neisen</span></h3>
<div class="p">
<sup>8</sup>Translational Science &amp; Experimental Medicine, Research and Early Development, Respiratory and Immunology (R&amp;I), BioPharmaceuticals R&amp;D, AstraZeneca, Cambridge, UK </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Neisen%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Jessica Neisen</span></a>
</div>
</div>
<sup>8</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Gehrmann%20U%22%5BAuthor%5D" class="usa-link" aria-describedby="id10"><span class="name western">Ulf Gehrmann</span></a><div hidden="hidden" id="id10">
<h3><span class="name western">Ulf Gehrmann</span></h3>
<div class="p">
<sup>7</sup>Translational Science &amp; Experimental Medicine, Research and Early Development, Respiratory and Immunology (R&amp;I), BioPharmaceuticals R&amp;D, AstraZeneca, Gothenburg, Sweden </div>
<div class="p">
<sup>12</sup>Present Address: Biomedical Research, Novartis, Basel, Switzerland </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Gehrmann%20U%22%5BAuthor%5D" class="usa-link"><span class="name western">Ulf Gehrmann</span></a>
</div>
</div>
<sup>7,</sup><sup>12</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Powell%20N%22%5BAuthor%5D" class="usa-link" aria-describedby="id11"><span class="name western">Nick Powell</span></a><div hidden="hidden" id="id11">
<h3><span class="name western">Nick Powell</span></h3>
<div class="p">
<sup>9</sup>Faculty of Medicine, Imperial College London, London, UK </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Powell%20N%22%5BAuthor%5D" class="usa-link"><span class="name western">Nick Powell</span></a>
</div>
</div>
<sup>9</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="Aff1">
<sup>1</sup>BioPharmaceutical Medical, Real World Science &amp; Analytics, AstraZeneca, Pepparedsleden 1, 431 83 Gothenburg, Sweden </div>
<div id="Aff2">
<sup>2</sup>BioPharmaceutical Medical, Real World Science &amp; Analytics, AstraZeneca, Cambridge, UK </div>
<div id="Aff3">
<sup>3</sup>Biometrics and Statistical Innovation, Late-Stage Development Respiratory &amp; Immunology, AstraZeneca, Gothenburg, Sweden </div>
<div id="Aff4">
<sup>4</sup>Crohn’s &amp; Colitis Foundation, New York, NY USA </div>
<div id="Aff5">
<sup>5</sup>Late Respiratory and Immunology (R&amp;I), BioPharmaceuticals R&amp;D, AstraZeneca, Durham, NC USA </div>
<div id="Aff6">
<sup>6</sup>Late Respiratory and Immunology (R&amp;I), BioPharmaceuticals R&amp;D, AstraZeneca, Cambridge, UK </div>
<div id="Aff7">
<sup>7</sup>Translational Science &amp; Experimental Medicine, Research and Early Development, Respiratory and Immunology (R&amp;I), BioPharmaceuticals R&amp;D, AstraZeneca, Gothenburg, Sweden </div>
<div id="Aff8">
<sup>8</sup>Translational Science &amp; Experimental Medicine, Research and Early Development, Respiratory and Immunology (R&amp;I), BioPharmaceuticals R&amp;D, AstraZeneca, Cambridge, UK </div>
<div id="Aff9">
<sup>9</sup>Faculty of Medicine, Imperial College London, London, UK </div>
<div id="Aff10">
<sup>10</sup>Present Address: Amsterdam UMC, Amsterdam, Netherlands </div>
<div id="Aff11">
<sup>11</sup>Present Address: GSK, Durham, NC USA </div>
<div id="Aff12">
<sup>12</sup>Present Address: Biomedical Research, Novartis, Basel, Switzerland </div>
<div class="author-notes p"><div class="fn" id="_fncrsp93pmc__">
<sup>✉</sup><p class="display-inline">Corresponding author.</p>
</div></div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2024 Nov 12; Accepted 2025 May 9; Collection date 2025.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© The Author(s) 2025</div>
<p><strong>Open Access</strong> This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <a href="https://creativecommons.org/licenses/by-nc-nd/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/licenses/by-nc-nd/4.0/</a>.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12365130  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40830140/" class="usa-link">40830140</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="Abs1"><h2>Abstract</h2>
<p id="Par1">The relationship between interleukin-22 and clinical characteristics of patients with inflammatory bowel disease is uncertain. We sought to determine whether plasma interleukin-22 concentrations are associated with disease activity in a large population of patients with inflammatory bowel disease. This was an observational study of patients with Crohn’s disease or ulcerative colitis in the Study of a Prospective Adult Research Cohort with IBD (SPARC IBD) from the IBD Plexus registry of the Crohn’s &amp; Colitis Foundation in the United States. Interleukin-22 concentrations were measured using an R&amp;D Systems human interleukin-22 enzyme-linked immunosorbent assay. Of 3993 patients included, 1604 with Crohn’s disease and 836 with ulcerative colitis had non-missing interleukin-22 baseline samples, of which 33% and 25%, respectively, were above the lower limit of quantification (7.8 pg/mL). Significantly more patients with moderate/severe disease activity had high interleukin-22 concentrations (above lower limit of quantification) versus those with remission/mild disease activity (Crohn’s disease: 44.7% vs. 30.0%, <em>P</em> &lt; 0.00001; ulcerative colitis: 39.8% vs. 23.0%, <em>P</em> &lt; 0.001). A multinomial logit model found approximately twice the odds of moderate/severe disease activity in those with high interleukin-22 versus low interleukin-22 (below lower limit of quantification). The strongest predictors of high interleukin-22 concentrations identified by a machine-learning algorithm were higher Short Crohn’s Disease Activity Index score in patients with Crohn’s disease and prescription of biologics in patients with ulcerative colitis. In summary, high interleukin-22 concentrations tended to be associated with higher disease activity in this large, real-world population of patients with inflammatory bowel disease.</p>
<section id="sec1"><h3 class="pmc_sec_title">Supplementary Information</h3>
<p>The online version contains supplementary material available at 10.1038/s41598-025-01939-7.</p></section><section id="kwd-group1" lang="en" class="kwd-group"><p><strong>Keywords:</strong> Crohn’s disease, Ulcerative colitis, Interleukin-22, Inflammatory bowel disease</p></section><section id="kwd-group2" class="kwd-group"><p><strong>Subject terms:</strong> Immunology, Crohn's disease, Ulcerative colitis, Inflammatory bowel disease, Biomarkers</p></section></section><section id="Sec1"><h2 class="pmc_sec_title">Introduction</h2>
<p id="Par6">Inflammatory bowel disease (IBD) is a collection of immune-mediated inflammatory diseases including Crohn’s disease (CD) and ulcerative colitis (UC). Both CD and UC are associated with serious complications such as impaired gastrointestinal function, strictures, increased risk of colorectal cancer, extraintestinal complications, and impaired health-related quality of life, including anxiety, depression, fatigue, and work impairment<sup><a href="#CR1" class="usa-link" aria-describedby="CR1">1</a>–<a href="#CR5" class="usa-link" aria-describedby="CR5">5</a></sup>. In line with the traditional view of CD, UC is increasingly being recognized as progressive in nature<sup><a href="#CR5" class="usa-link" aria-describedby="CR5">5</a></sup>. Thus, early treatment with disease-modifying drugs is important in controlling inflammation and slowing the development of complications.</p>
<p id="Par7">There is overlap in the pathophysiology of CD and UC<sup><a href="#CR6" class="usa-link" aria-describedby="CR6">6</a>,<a href="#CR7" class="usa-link" aria-describedby="CR7">7</a></sup>. The interleukin (IL)-23 pathway is a major driver of IBD<sup><a href="#CR8" class="usa-link" aria-describedby="CR8">8</a>–<a href="#CR11" class="usa-link" aria-describedby="CR11">11</a></sup>. IL-22 is induced by IL-23 and is a key cytokine in the pathogenesis of IBD<sup><a href="#CR12" class="usa-link" aria-describedby="CR12">12</a>,<a href="#CR13" class="usa-link" aria-describedby="CR13">13</a></sup>. IL-22 is produced by different subsets of immune cells and has been shown to have protective effects on intestinal barrier function<sup><a href="#CR14" class="usa-link" aria-describedby="CR14">14</a></sup>. While IL-22 may be protective in acute tissue injury, chronic expression of IL-22 may promote inflammation and has been shown to exacerbate colitis<sup><a href="#CR13" class="usa-link" aria-describedby="CR13">13</a>,<a href="#CR15" class="usa-link" aria-describedby="CR15">15</a>–<a href="#CR18" class="usa-link" aria-describedby="CR18">18</a></sup>.</p>
<p id="Par8">Studies have suggested a relationship between IL-22 levels and IBD. For example, patients with CD and UC have increased IL-22 expression in colonic tissue<sup><a href="#CR15" class="usa-link" aria-describedby="CR15">15</a>,<a href="#CR19" class="usa-link" aria-describedby="CR19">19</a></sup>. Furthermore, IL-22 concentrations in colonic tissue in patients with UC and serum IL-22 concentrations in patients with CD have been found to correlate with disease activity in small populations of patients from a variety of clinical settings<sup><a href="#CR12" class="usa-link" aria-describedby="CR12">12</a>,<a href="#CR18" class="usa-link" aria-describedby="CR18">18</a>,<a href="#CR20" class="usa-link" aria-describedby="CR20">20</a></sup>. Further supporting a link between IL-22 and disease activity, one study showed that among patients receiving brazikumab, an IL-23 inhibitor, remission rates were higher in patients with high serum IL-22 than those with low serum IL-22 at baseline<sup><a href="#CR21" class="usa-link" aria-describedby="CR21">21</a></sup>. Thus, circulating IL-22 concentrations may have clinical relevance as a biomarker in patients with IBD.</p>
<p id="Par9">Given the potential relevance of IL-22 as a biomarker, it is important to understand which diseases and clinical characteristics impact IL-22 concentrations. Real-world studies are critical to confirm this association. IBD Plexus is a US patient registry owned by the Crohn’s &amp; Colitis Foundation that consists of several cohorts, including the Study of a Prospective Adult Research Cohort with IBD (SPARC IBD) cohort<sup><a href="#CR22" class="usa-link" aria-describedby="CR22">22</a></sup>. The SPARC IBD cohort enrolls patients diagnosed with CD, UC, or unclassified IBD. The aim of this observational study was to evaluate the association of IL-22 concentrations and the severity of CD and UC, with higher IL-22 concentrations expected to be associated with greater disease severity based on the literature described above.</p></section><section id="Sec2"><h2 class="pmc_sec_title">Methods</h2>
<section id="Sec3"><h3 class="pmc_sec_title">Study design</h3>
<p id="Par10">This is a cross-sectional study of patients in the SPARC IBD cohort from the IBD Plexus registry, a data ecosystem owned by the Crohn’s &amp; Colitis Foundation. This study used patient data entered in SPARC IBD from initiation in 2016 to January 2022. Patients from SPARC IBD were divided into two cohorts: those with CD and those with UC.</p>
<p id="Par11">The use of SPARC IBD and blood plasma samples for this study was approved by the Crohn’s &amp; Colitis Foundation in 2021. This study was conducted according to US and international standards of Good Clinical Practice (FDA Title 21 part 312 and International Conference on Harmonization guidelines), applicable government regulations and institutional research policies and procedures. The study protocol was approved by the Institutional Review Board (IRB) at the University of Pennsylvania, which is the single IRB for the SPARC IBD study.</p></section><section id="Sec4"><h3 class="pmc_sec_title">Patients</h3>
<p id="Par12">Adult patients (age 18 years or older) with either CD or UC diagnosis and an identifiable index date were included in the study. Patients were excluded if they had indeterminate colitis (e.g., having a diagnosis of both CD and UC, or unspecified IBD). All patients enrolled in the study provided informed consent to participate through a universal consent form authorizing use of their personal information for future IBD studies. These data include information about health and health-related issues, information collected from the medical record, insurance claims data, and biosamples collected as part of the research study. SPARC has allowed for both paper and e-consent since 2020 (due to the COVID-19 pandemic), prior to which consent was obtained via a paper-based form.</p></section><section id="Sec5"><h3 class="pmc_sec_title">Assessments</h3>
<p id="Par13">Data were collected from patient- and provider-reported surveys along with individual electronic medical records and structured electronic case report forms. Patient blood plasma samples stored in SPARC IBD were used to measure IL-22 concentrations. IL-22 concentrations were measured using an R&amp;D Systems (Minneapolis, MN, USA) human IL-22 enzyme-linked immunosorbent assay kit according to the manufacturer’s instructions. In brief, samples were thawed to room temperature, diluted 1:1 in assay diluent RD1-88 and incubated for 2 h at room temperature in pre-coated 96-well microplate strips. Samples were analyzed in duplicates. Following incubation, wells were washed 4 times using wash buffer, 200 µL human anti-IL-22 conjugate was added and incubated for 2 h at room temperature, wells were again washed 4 times, and 200 µL substrate solution was added and incubated for 30 min at room temperature before 50 µL stop solution was added. Within 30 min, optical density of the final solution was determined using a microplate reader set to 450 nm, with wavelength correction at 540 nm. Final IL-22 concentrations were extrapolated using optical density measurements and the standard curve measurements, run in parallel on each plate, and fitted with a 4-parameter curve with inverse response weighting (1/Y).</p>
<p id="Par14">IL-22 concentrations were categorized as low (at or below the lower limit of quantitation [LLOQ]) or high (&gt; LLOQ). Baseline demographics were assessed descriptively in the overall population and disease characteristics were assessed descriptively both in the overall population and stratified by IL-22 level. IL-17A was measured by high-sensitivity single-molecule array (Simoa) assay (Rules-Based Medicine, Austin TX, USA).</p>
<p id="Par15">All clinical data considered for any analysis were assessed during the baseline period, which is defined as within 30 days of the index date (the index date was set as the enrollment date as identified through date of consent). If more than one value of a variable was registered during the baseline period, the value closest in time to the index date was defined as the baseline value.</p></section><section id="Sec6"><h3 class="pmc_sec_title">Statistical analyses</h3>
<p id="Par16">This study is a hypothesis-generating, exploratory study; no formal power calculations were performed. All available patients in the CD and UC cohorts were included.</p>
<section id="Sec7"><h4 class="pmc_sec_title">Cluster analysis</h4>
<p id="Par17">An unsupervised cluster analysis was performed for each IL-22 cohort (IL-22 all, IL-22 high, and IL-22 low) to identify groups of patients with similar characteristics. Input variables included demographics (age, sex, race), disease characteristics (disease duration, 6-point Ulcerative Colitis Disease Activity Score [UCDAI] or short Crohn’s Disease Activity Index [sCDAI] score, phenotype, extraintestinal manifestations), symptom variables, treatments, and comorbidities. Only variables with ≤ 30% missing values were included. Categorical variables included had a minor category proportion of at least 5%. A dissimilarity matrix was created by averaging 5 separate dissimilarity matrices. These matrices were generated using a random forest model with 2000 decision trees. In building each tree, a standard approach of selecting a random subset of variables was followed, specifically the square root of the total number of variables. The centroid clustering model algorithm partitioning around the medoid (PAM) was used to select clusters.</p>
<p id="Par19">Results from the cluster analysis were visualized by plotting in a 2-dimensional space using uniform manifold approximation and projection (UMAP) as a dimensionality reduction technique.</p></section><section id="Sec8"><h4 class="pmc_sec_title">Association model</h4>
<p id="Par20">The association between IL-22 concentration and disease activity was assessed using a multinomial logit model. The response variable was disease activity, which had 3 categories: remission (sCDAI &lt; 150 or 6-point UCDAI ≤ 1), mild (sCDAI 150–219 or 6-point UCDAI 2–3), and moderate/severe (sCDAI ≥ 220 or 6-point UCDAI ≥ 4). The remission category was used as reference. The exposure was IL-22 level, categorized as IL-22 low (&lt; LLOQ) and high (≥ LLOQ). Odds ratios (ORs) for having mild or moderate/severe disease activity for those with higher IL-22 were compared with the odds for those with low IL-22. The following covariates were identified as potential confounders or risk factors and were adjusted for in the model: age, sex, disease duration, comorbidities, and main treatment classes. The variable selection for the association model was based on a combination of evidence from the literature, discussion with medical experts, and statistical considerations (e.g., amount of missing data and model robustness considerations). Only variables with ≤ 10% missingness were included.</p></section><section id="Sec9"><h4 class="pmc_sec_title">Relevance of variables predictive of IL-22 level: eXtreme gradient boosting (XGBoost) and SHapley additive explanations (SHAP)</h4>
<p id="Par21">XGBoost<sup><a href="#CR23" class="usa-link" aria-describedby="CR23">23</a></sup> was utilized to classify IL-22 concentration levels as high or low based on available demographic and clinical features (variables). The resulting model was used to interpret IL-22 level predictions using SHAP values<sup><a href="#CR24" class="usa-link" aria-describedby="CR24">24</a></sup>. A stratified train-test split with a 70:30 ratio was employed, which preserves the proportion of the 2 (binary) classes (i.e., high IL-22, low IL-22) in the training and test set. The training set was used for the XGBoost model to learn patterns in the data by utilizing the available variables per patient and their corresponding IL-22 concentration label (high or low; category). The test set was used for inference and assessing the performance of the model with area under the receiver operating curve (ROC-AUC) (i.e., extent to which the model correctly discriminates between the 2 labels). To improve the performance of the XGBoost model, we carried out hyperparameter tuning. A detailed account of the scanned hyperparameters and the selected values for attaining optimal performance are provided in Table <a href="#MOESM1" class="usa-link">S1</a>, Online Resource 1. Finally, SHAP values were estimated using the trained XGBoost model. SHAP values allow interpretation of why the model predicts a specific IL-22 concentration category per patient based on the available variables. For a given variable, a high positive SHAP value is predictive of high IL-22 and a negative SHAP value is predictive of low IL-22.</p></section><section id="Sec10"><h4 class="pmc_sec_title">Software</h4>
<p id="Par22">Python version 3.9.7 and R version 4.2.1 were used for the cluster analysis. For clustering, the randomForest version 4.7–1.1 and diceR version 1.2.2 packages were used. The Python UMAP package version 0.5.3 was used to produce UMAP plots for each cohort. Python version 3.9.7 and package XGBoost version 1.7.1 with Scikit learn version 1.1.3 were used for implementing the XGBoost model, and SHAP values were estimated and visualized with SHAP package version 0.41.0. The whole analysis was carried out with the random seed set at 42.</p></section></section></section><section id="Sec11"><h2 class="pmc_sec_title">Results</h2>
<section id="Sec12"><h3 class="pmc_sec_title">Population characteristics</h3>
<p id="Par23">Of 2830 patients with CD and 1431 patients with UC in the registry, 2667 patients with CD and 1326 with UC had clinical data available (Figure <a href="#MOESM1" class="usa-link">S1</a>, Online Resource 1). For patients with CD, median age was 39.0 years, 56.7% were female, and median disease duration was 13.0 years (Table <a href="#Tab1" class="usa-link">1</a>). For patients with UC, median age was 40.0 years, 50.5% were female, and median disease duration was 9.0 years (Table <a href="#Tab1" class="usa-link">1</a>).</p>
<section class="tw xbox font-sm" id="Tab1"><h4 class="obj_head">Table 1.</h4>
<div class="caption p"><p>Patient demographics.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="left" colspan="1" rowspan="1"></th>
<th align="left" colspan="1" rowspan="1">CD (<em>n</em> = 2667)</th>
<th align="left" colspan="1" rowspan="1">UC (<em>n</em> = 1326)</th>
</tr></thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">Age, median (Q1, Q3), years</td>
<td align="left" colspan="1" rowspan="1">39.0 (29.0, 52.0)</td>
<td align="left" colspan="1" rowspan="1">40.0 (30.0, 54.0)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Female, n (%)</td>
<td align="left" colspan="1" rowspan="1">1513 (56.7)</td>
<td align="left" colspan="1" rowspan="1">670 (50.5)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Disease duration, median (Q1, Q3), years</td>
<td align="left" colspan="1" rowspan="1">13.0 (7.0, 21.0)</td>
<td align="left" colspan="1" rowspan="1">9.0 (4.0, 16.0)</td>
</tr>
<tr><td align="left" colspan="3" rowspan="1">Race and ethnicity, n (%)</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> White not Hispanic</td>
<td align="left" colspan="1" rowspan="1">1961 (73.5)</td>
<td align="left" colspan="1" rowspan="1">1001 (75.5)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Black not Hispanic</td>
<td align="left" colspan="1" rowspan="1">201 (7.5)</td>
<td align="left" colspan="1" rowspan="1">56 (4.2)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Hispanic</td>
<td align="left" colspan="1" rowspan="1">37 (1.4)</td>
<td align="left" colspan="1" rowspan="1">33 (2.5)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Asian not Hispanic</td>
<td align="left" colspan="1" rowspan="1">26 (1.0)</td>
<td align="left" colspan="1" rowspan="1">33 (2.5)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Other not Hispanic</td>
<td align="left" colspan="1" rowspan="1">16 (0.6)</td>
<td align="left" colspan="1" rowspan="1">17 (1.3)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Missing</td>
<td align="left" colspan="1" rowspan="1">426 (16.0)</td>
<td align="left" colspan="1" rowspan="1">186 (14.0)</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="_fn_p23"><p><em>CD</em> Crohn’s disease, <em>Q</em> quartile, <em>UC</em> ulcerative colitis.</p></div></div></section><p id="Par24">The final study population only included patients with plasma available for quantifying IL-22 and a non-missing IL-22 value (Figure <a href="#MOESM1" class="usa-link">S1</a>, Online Resource 1). Plasma IL-22 concentrations were analyzed in 1604 patients with CD and 836 patients with UC (Figure <a href="#MOESM1" class="usa-link">S1</a>, Online Resource 1). Among patients with IL-22 values, 32.9% of the CD cohort and 25.2% of the UC cohort were above the LLOQ (7.8 pg/mL). For patients with CD, median (Q1, Q3) IL-22 concentrations were &lt; LLOQ (&lt; LLOQ, 10.8 pg/mL). For patients with UC, median (Q1, Q3) IL-22 concentrations were &lt; LLOQ (&lt; LLOQ, 7.9 pg/mL). Most patients were in clinical remission based on sCDAI or 6-point UCDAI (CD: 59.8%; UC: 63.8%) (Table <a href="#Tab2" class="usa-link">2</a>). IBD-associated arthropathy was the most common extraintestinal manifestation. Rates of extraintestinal manifestations were similar between patients with low and high IL-22 concentrations. Patients with CD were most commonly receiving treatment with anti–tumor necrosis factor-α (TNFα) therapy, immunomodulators, and corticosteroids at baseline. Patients with UC were most commonly receiving treatment with aminosalicylates, anti-TNFα therapy, and corticosteroids at baseline. Greater proportions of patients with high IL-22 concentrations were receiving treatment with biologics than patients with low IL-22 (Table <a href="#Tab2" class="usa-link">2</a>). Anti-TNFα therapy in particular was more common in those with high IL-22 concentrations (CD: 65.5%, UC: 58.8%) than those with low IL-22 concentrations (CD: 54.2%, UC: 39.8%).</p>
<section class="tw xbox font-sm" id="Tab2"><h4 class="obj_head">Table 2.</h4>
<div class="caption p"><p>Disease characteristics in the IL-22 cohort.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" rowspan="2" colspan="1"></th>
<th align="left" colspan="3" rowspan="1">CD</th>
<th align="left" colspan="3" rowspan="1">UC</th>
</tr>
<tr>
<th align="left" colspan="1" rowspan="1">IL-22 low<sup>a</sup><br>(<em>n</em> = 1077)</th>
<th align="left" colspan="1" rowspan="1">IL-22 high<sup>b</sup><br>(<em>n</em> = 527)</th>
<th align="left" colspan="1" rowspan="1">Total<br>(<em>n</em> = 1604)</th>
<th align="left" colspan="1" rowspan="1">IL-22 low<sup>a</sup><br>(<em>n</em> = 625)</th>
<th align="left" colspan="1" rowspan="1">IL-22 high<sup>b</sup><br>(<em>n</em> = 211)</th>
<th align="left" colspan="1" rowspan="1">Total<br>(<em>n</em> = 836)</th>
</tr>
</thead>
<tbody>
<tr><td align="left" colspan="7" rowspan="1">sCDAI/6-point UCDAI category, n (%)</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Remission (sCDAI &lt; 150/6-point UCDAI ≤ 1)</td>
<td align="left" colspan="1" rowspan="1">686 (63.7)</td>
<td align="left" colspan="1" rowspan="1">273 (51.8)</td>
<td align="left" colspan="1" rowspan="1">959 (59.8)</td>
<td align="left" colspan="1" rowspan="1">426 (68.2)</td>
<td align="left" colspan="1" rowspan="1">107 (50.7)</td>
<td align="left" colspan="1" rowspan="1">533 (63.8)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Mild (sCDAI 150–219/6-point UCDAI 2–3)</td>
<td align="left" colspan="1" rowspan="1">216 (20.1)</td>
<td align="left" colspan="1" rowspan="1">114 (21.6)</td>
<td align="left" colspan="1" rowspan="1">330 (20.6)</td>
<td align="left" colspan="1" rowspan="1">133 (21.3)</td>
<td align="left" colspan="1" rowspan="1">60 (28.4)</td>
<td align="left" colspan="1" rowspan="1">193 (23.1)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Moderate (sCDAI 220–450/6-point UCDAI 4–5)</td>
<td align="left" colspan="1" rowspan="1">165 (15.3)</td>
<td align="left" colspan="1" rowspan="1">125 (23.7)</td>
<td align="left" colspan="1" rowspan="1">290 (18.1)</td>
<td align="left" colspan="1" rowspan="1">55 (8.8)</td>
<td align="left" colspan="1" rowspan="1">30 (14.2)</td>
<td align="left" colspan="1" rowspan="1">85 (10.2)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Severe (sCDAI &gt; 450/6-point UCDAI 6)</td>
<td align="left" colspan="1" rowspan="1">6 (0.6)</td>
<td align="left" colspan="1" rowspan="1">13 (2.5)</td>
<td align="left" colspan="1" rowspan="1">19 (1.2)</td>
<td align="left" colspan="1" rowspan="1">10 (1.6)</td>
<td align="left" colspan="1" rowspan="1">13 (6.2)</td>
<td align="left" colspan="1" rowspan="1">23 (2.8)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Missing</td>
<td align="left" colspan="1" rowspan="1">4 (0.4)</td>
<td align="left" colspan="1" rowspan="1">2 (0.4)</td>
<td align="left" colspan="1" rowspan="1">6 (0.4)</td>
<td align="left" colspan="1" rowspan="1">1 (0.2)</td>
<td align="left" colspan="1" rowspan="1">1 (0.5)</td>
<td align="left" colspan="1" rowspan="1">2 (0.2)</td>
</tr>
<tr><td align="left" colspan="7" rowspan="1">CD phenotype</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Inflammatory, non-penetrating, non-stricturing</td>
<td align="left" colspan="1" rowspan="1">329 (30.5)</td>
<td align="left" colspan="1" rowspan="1">130 (24.7)</td>
<td align="left" colspan="1" rowspan="1">459 (28.6)</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Stricturing</td>
<td align="left" colspan="1" rowspan="1">176 (16.3)</td>
<td align="left" colspan="1" rowspan="1">96 (18.2)</td>
<td align="left" colspan="1" rowspan="1">272 (17.0)</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Penetrating</td>
<td align="left" colspan="1" rowspan="1">138 (12.8)</td>
<td align="left" colspan="1" rowspan="1">84 (15.9)</td>
<td align="left" colspan="1" rowspan="1">222 (13.8)</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Both stricturing and penetrating</td>
<td align="left" colspan="1" rowspan="1">174 (16.2)</td>
<td align="left" colspan="1" rowspan="1">101 (19.2)</td>
<td align="left" colspan="1" rowspan="1">275 (17.1)</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Missing</td>
<td align="left" colspan="1" rowspan="1">260 (24.1)</td>
<td align="left" colspan="1" rowspan="1">116 (22.0)</td>
<td align="left" colspan="1" rowspan="1">376 (23.4)</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
</tr>
<tr><td align="left" colspan="7" rowspan="1">CD location</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Colonic</td>
<td align="left" colspan="1" rowspan="1">106 (9.8)</td>
<td align="left" colspan="1" rowspan="1">50 (9.5)</td>
<td align="left" colspan="1" rowspan="1">156 (9.7)</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Ileal</td>
<td align="left" colspan="1" rowspan="1">148 (13.7)</td>
<td align="left" colspan="1" rowspan="1">51 (9.7)</td>
<td align="left" colspan="1" rowspan="1">199 (12.4)</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Ileocolonic</td>
<td align="left" colspan="1" rowspan="1">396 (36.8)</td>
<td align="left" colspan="1" rowspan="1">223 (42.3)</td>
<td align="left" colspan="1" rowspan="1">619 (38.6)</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Upper GI only</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">1 (0.2)</td>
<td align="left" colspan="1" rowspan="1">1 (0.1)</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Missing</td>
<td align="left" colspan="1" rowspan="1">420 (39.0)</td>
<td align="left" colspan="1" rowspan="1">199 (37.8)</td>
<td align="left" colspan="1" rowspan="1">619 (38.6)</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
</tr>
<tr><td align="left" colspan="7" rowspan="1">UC phenotype</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Ulcerative proctitis</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">61 (9.8)</td>
<td align="left" colspan="1" rowspan="1">21 (10.0)</td>
<td align="left" colspan="1" rowspan="1">82 (9.8)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Left-sided</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">121 (19.4)</td>
<td align="left" colspan="1" rowspan="1">32 (15.2)</td>
<td align="left" colspan="1" rowspan="1">153 (18.3)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Extensive</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">45 (7.2)</td>
<td align="left" colspan="1" rowspan="1">20 (9.5)</td>
<td align="left" colspan="1" rowspan="1">65 (7.8)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Pancolitis</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">253 (40.5)</td>
<td align="left" colspan="1" rowspan="1">73 (34.6)</td>
<td align="left" colspan="1" rowspan="1">326 (39.0)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Missing</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">145 (23.2)</td>
<td align="left" colspan="1" rowspan="1">65 (30.8)</td>
<td align="left" colspan="1" rowspan="1">210 (25.1)</td>
</tr>
<tr><td align="left" colspan="7" rowspan="1">Extraintestinal manifestations, n (%)</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> IBD-associated arthropathy</td>
<td align="left" colspan="1" rowspan="1">148 (13.7)</td>
<td align="left" colspan="1" rowspan="1">90 (17.1)</td>
<td align="left" colspan="1" rowspan="1">238 (14.8)</td>
<td align="left" colspan="1" rowspan="1">75 (12.0)</td>
<td align="left" colspan="1" rowspan="1">23 (10.9)</td>
<td align="left" colspan="1" rowspan="1">98 (11.7)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Aphthous ulcer</td>
<td align="left" colspan="1" rowspan="1">50 (4.6)</td>
<td align="left" colspan="1" rowspan="1">33 (6.3)</td>
<td align="left" colspan="1" rowspan="1">83 (5.2)</td>
<td align="left" colspan="1" rowspan="1">23 (3.7)</td>
<td align="left" colspan="1" rowspan="1">13 (6.2)</td>
<td align="left" colspan="1" rowspan="1">36 (4.3)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Erythema nodosum</td>
<td align="left" colspan="1" rowspan="1">25 (2.3)</td>
<td align="left" colspan="1" rowspan="1">14 (2.7)</td>
<td align="left" colspan="1" rowspan="1">39 (2.4)</td>
<td align="left" colspan="1" rowspan="1">6 (1.0)</td>
<td align="left" colspan="1" rowspan="1">2 (0.9)</td>
<td align="left" colspan="1" rowspan="1">8 (1.0)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Pyoderma gangrenosum</td>
<td align="left" colspan="1" rowspan="1">5 (0.5)</td>
<td align="left" colspan="1" rowspan="1">8 (1.5)</td>
<td align="left" colspan="1" rowspan="1">13 (0.8)</td>
<td align="left" colspan="1" rowspan="1">3 (0.5)</td>
<td align="left" colspan="1" rowspan="1">N/A</td>
<td align="left" colspan="1" rowspan="1">3 (0.4)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Primary sclerosing cholangitis</td>
<td align="left" colspan="1" rowspan="1">22 (2.0)</td>
<td align="left" colspan="1" rowspan="1">2 (0.4)</td>
<td align="left" colspan="1" rowspan="1">24 (1.5)</td>
<td align="left" colspan="1" rowspan="1">32 (5.1)</td>
<td align="left" colspan="1" rowspan="1">5 (2.4)</td>
<td align="left" colspan="1" rowspan="1">37 (4.4)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Thrombotic complications</td>
<td align="left" colspan="1" rowspan="1">11 (1.0)</td>
<td align="left" colspan="1" rowspan="1">5 (0.9)</td>
<td align="left" colspan="1" rowspan="1">16 (1.0)</td>
<td align="left" colspan="1" rowspan="1">3 (0.5)</td>
<td align="left" colspan="1" rowspan="1">7 (3.3)</td>
<td align="left" colspan="1" rowspan="1">10 (1.2)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> None reported</td>
<td align="left" colspan="1" rowspan="1">782 (72.6)</td>
<td align="left" colspan="1" rowspan="1">356 (67.6)</td>
<td align="left" colspan="1" rowspan="1">1138 (70.9)</td>
<td align="left" colspan="1" rowspan="1">477 (76.3)</td>
<td align="left" colspan="1" rowspan="1">157 (74.4)</td>
<td align="left" colspan="1" rowspan="1">634 (75.8)</td>
</tr>
<tr><td align="left" colspan="7" rowspan="1">Treatment received at baseline<sup>c</sup>, n (%)</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Aminosalicylates</td>
<td align="left" colspan="1" rowspan="1">176 (16.3)</td>
<td align="left" colspan="1" rowspan="1">93 (17.6)</td>
<td align="left" colspan="1" rowspan="1">269 (16.8)</td>
<td align="left" colspan="1" rowspan="1">349 (55.8)</td>
<td align="left" colspan="1" rowspan="1">105 (49.8)</td>
<td align="left" colspan="1" rowspan="1">454 (54.3)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Antibiotics<sup>d</sup>
</td>
<td align="left" colspan="1" rowspan="1">30 (2.8)</td>
<td align="left" colspan="1" rowspan="1">27 (5.1)</td>
<td align="left" colspan="1" rowspan="1">57 (3.6)</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
<td align="left" colspan="1" rowspan="1">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Biologics</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Anti-TNFα</td>
<td align="left" colspan="1" rowspan="1">584 (54.2)</td>
<td align="left" colspan="1" rowspan="1">345 (65.5)</td>
<td align="left" colspan="1" rowspan="1">929 (57.9)</td>
<td align="left" colspan="1" rowspan="1">249 (39.8)</td>
<td align="left" colspan="1" rowspan="1">124 (58.8)</td>
<td align="left" colspan="1" rowspan="1">373 (44.6)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Anti-integrins</td>
<td align="left" colspan="1" rowspan="1">175 (16.2)</td>
<td align="left" colspan="1" rowspan="1">96 (18.2)</td>
<td align="left" colspan="1" rowspan="1">271 (16.9)</td>
<td align="left" colspan="1" rowspan="1">172 (27.5)</td>
<td align="left" colspan="1" rowspan="1">49 (23.2)</td>
<td align="left" colspan="1" rowspan="1">221 (26.4)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Ustekinumab</td>
<td align="left" colspan="1" rowspan="1">322 (29.9)</td>
<td align="left" colspan="1" rowspan="1">179 (34.0)</td>
<td align="left" colspan="1" rowspan="1">501 (31.2)</td>
<td align="left" colspan="1" rowspan="1">76 (12.2)</td>
<td align="left" colspan="1" rowspan="1">36 (17.1)</td>
<td align="left" colspan="1" rowspan="1">112 (13.4)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Corticosteroids</td>
<td align="left" colspan="1" rowspan="1">313 (29.1)</td>
<td align="left" colspan="1" rowspan="1">190 (36.1)</td>
<td align="left" colspan="1" rowspan="1">503 (31.4)</td>
<td align="left" colspan="1" rowspan="1">215 (34.4)</td>
<td align="left" colspan="1" rowspan="1">82 (38.9)</td>
<td align="left" colspan="1" rowspan="1">297 (35.5)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Immunomodulators<sup>e</sup>
</td>
<td align="left" colspan="1" rowspan="1">409 (38.0)</td>
<td align="left" colspan="1" rowspan="1">230 (43.6)</td>
<td align="left" colspan="1" rowspan="1">639 (39.8)</td>
<td align="left" colspan="1" rowspan="1">209 (33.4)</td>
<td align="left" colspan="1" rowspan="1">83 (39.3)</td>
<td align="left" colspan="1" rowspan="1">292 (34.9)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> JAK inhibitor</td>
<td align="left" colspan="1" rowspan="1">10 (0.9)</td>
<td align="left" colspan="1" rowspan="1">9 (1.7)</td>
<td align="left" colspan="1" rowspan="1">19 (1.2)</td>
<td align="left" colspan="1" rowspan="1">50 (8.0)</td>
<td align="left" colspan="1" rowspan="1">29 (13.7)</td>
<td align="left" colspan="1" rowspan="1">79 (9.4)</td>
</tr>
<tr><td align="left" colspan="7" rowspan="1">Number of IBD surgeries</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> 0</td>
<td align="left" colspan="1" rowspan="1">381 (35.4)</td>
<td align="left" colspan="1" rowspan="1">170 (32.3)</td>
<td align="left" colspan="1" rowspan="1">551 (34.4)</td>
<td align="left" colspan="1" rowspan="1">344 (55.0)</td>
<td align="left" colspan="1" rowspan="1">125 (59.2)</td>
<td align="left" colspan="1" rowspan="1">469 (56.1)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> 1</td>
<td align="left" colspan="1" rowspan="1">75 (7.0)</td>
<td align="left" colspan="1" rowspan="1">42 (8.0)</td>
<td align="left" colspan="1" rowspan="1">117 (7.3)</td>
<td align="left" colspan="1" rowspan="1">8 (1.3)</td>
<td align="left" colspan="1" rowspan="1">2 (0.9)</td>
<td align="left" colspan="1" rowspan="1">10 (1.2)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> 2+</td>
<td align="left" colspan="1" rowspan="1">78 (7.2)</td>
<td align="left" colspan="1" rowspan="1">25 (4.7)</td>
<td align="left" colspan="1" rowspan="1">103 (6.4)</td>
<td align="left" colspan="1" rowspan="1">10 (1.6)</td>
<td align="left" colspan="1" rowspan="1">1 (0.5)</td>
<td align="left" colspan="1" rowspan="1">11 (1.3)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Missing</td>
<td align="left" colspan="1" rowspan="1">543 (50.4)</td>
<td align="left" colspan="1" rowspan="1">290 (55.0)</td>
<td align="left" colspan="1" rowspan="1">833 (51.9)</td>
<td align="left" colspan="1" rowspan="1">263 (42.1)</td>
<td align="left" colspan="1" rowspan="1">83 (39.3)</td>
<td align="left" colspan="1" rowspan="1">346 (41.4)</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="_fn_p26">
<p><sup>a</sup>IL-22 ≤ LLOQ.</p>
<p><sup>b</sup>IL-22 &gt; LLOQ.</p>
<p><sup>c</sup>Patients may have received ≥ 1 type of treatment.</p>
<p><sup>d</sup>Including ciprofloxacin, clarithromycin, metronidazole, and rifaximin.</p>
<p><sup>e</sup>Including azathioprine, cyclosporine, mercaptopurine, methotrexate, and tacrolimus.</p>
<p><em>CD</em> Crohn’s disease, <em>IBD</em> inflammatory bowel disease, <em>IL-22</em> interleukin-22, <em>JAK</em> Janus kinase, <em>TNF</em> tumor necrosis factor, <em>sCDAI</em> short Crohn’s disease activity index measuring disease severity, <em>UC</em> ulcerative colitis, <em>UCDAI</em> ulcerative colitis disease activity index measuring disease severity.</p>
</div></div></section></section><section id="Sec13"><h3 class="pmc_sec_title">Association of plasma IL-22 concentration and disease severity/activity</h3>
<p id="Par27">We evaluated plasma IL-22 concentrations in CD and UC patients stratified by disease activity. In patients with CD, significantly (<em>P</em> &lt; 0.00001) more patients had low IL-22 concentrations among those in remission or with mild disease activity (70.0%) compared with those with moderate/severe disease activity (55.3%), and conversely, significantly (<em>P</em> &lt; 0.00001) more patients with moderate/severe disease activity had high IL-22 concentrations (44.7%) than those in remission or with mild disease activity (30.0%) (Fig. <a href="#Fig1" class="usa-link">1</a>A). A similar pattern was seen in patients with UC (<em>P</em> &lt; 0.001; Fig. <a href="#Fig1" class="usa-link">1</a>B). Furthermore, among patients with moderate/severe disease activity, more patients had IL-22 concentrations above the third quartile compared with those in remission/low disease activity, both in patients with CD and those with UC (Fig. <a href="#Fig2" class="usa-link">2</a>). Comparison of subgroups of patients with low and high IL-22 concentrations showed a consistent pattern, with a lower proportion of patients in remission and a greater proportion of patients with moderate/severe disease in the high IL-22 group than in the low IL-22 group (Table S2, Online Resource 1).</p>
<figure class="fig xbox font-sm" id="Fig1"><h4 class="obj_head">Fig. 1.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2f0/12365130/f771bf0d55b7/41598_2025_1939_Fig1_HTML.jpg" loading="lazy" id="d33e1422" height="702" width="745" alt="Fig. 1"></p>
<div class="p text-right font-secondary"><a href="figure/Fig1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Proportions of patients with low<sup>a</sup> and high<sup>b</sup> IL-22 by disease activity. <sup>a</sup>IL-22 ≤ LLOQ. <sup>b</sup>IL-22 &gt; LLOQ. LLOQ = 7.8 pg/mL. (<strong>A</strong>) CD. (<strong>B</strong>) UC. <em>P</em>-values were calculated by chi-square test. <em>CD</em> Crohn’s disease, <em>IL-22</em> interleukin-22, <em>LLOQ</em> lower limit of quantification, <em>Q3</em> third quartile, <em>UC</em> ulcerative colitis.</p></figcaption></figure><figure class="fig xbox font-sm" id="Fig2"><h4 class="obj_head">Fig. 2.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12365130_41598_2025_1939_Fig2_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2f0/12365130/1bf4a4ba9611/41598_2025_1939_Fig2_HTML.jpg" loading="lazy" id="d33e1456" height="320" width="694" alt="Fig. 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Proportions of patients with plasma IL-22 concentrations ≥ Q3<sup>a</sup> by disease activity. <sup>a</sup>Q3 = 10.8 pg/mL in CD, 7.9 pg/mL in UC. <em>CD</em> Crohn’s disease, <em>IL-22</em> interleukin-22, <em>Q3</em> third quartile, <em>sCDAI</em> short Crohn’s disease activity index, <em>UC</em> ulcerative colitis, <em>UCDAI</em> ulcerative colitis disease activity index.</p></figcaption></figure></section><section id="Sec14"><h3 class="pmc_sec_title">Cluster analysis</h3>
<p id="Par30">An unsupervised cluster analysis was performed to determine whether any demographic or disease characteristics cluster together in IBD patients and whether this varies by IL-22 concentration. Three distinct clusters were identified for patients with CD in the IL-22 all cohort (Fig. <a href="#Fig3" class="usa-link">3</a>A). The first cluster consisted mainly of patients with moderate and severe disease activity (Table S3, Online Resource 1). In the second cluster, 99.3% of patients were in remission, and in the last cluster, 62.0% of patients were in remission and 24.1% had mild disease activity. Among patients with IL-22 high, two clusters were identified (Fig. <a href="#Fig3" class="usa-link">3</a>A), characterized mainly by differences in disease activity (Table S3, Online Resource 1). In the population of patients with IL-22 low, four clusters were identified, which seemed to be mainly characterized by differences both in age and disease activity (Fig. <a href="#Fig3" class="usa-link">3</a>A, Table S3, Online Resource 1).</p>
<figure class="fig xbox font-sm" id="Fig3"><h4 class="obj_head">Fig. 3.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12365130_41598_2025_1939_Fig3_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2f0/12365130/b1c0a3ca70a1/41598_2025_1939_Fig3_HTML.jpg" loading="lazy" id="d33e1518" height="393" width="652" alt="Fig. 3"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>UMAP plot of clustering in the IL-22 all, IL-22 high<sup>a</sup>, and IL-22 low<sup>b</sup> cohorts. (<strong>A</strong>) CD. (<strong>B</strong>) UC. Each data point corresponds to 1 patient. The high-dimensional variables for each patient have been mapped to a 2-dimensional setting, allowing for visualization and interpretation of the clustering analysis. Each cluster is shown with a different color. <sup>a</sup>IL-22 &gt; LLOQ. <sup>b</sup>IL-22 ≤ LLOQ. <em>CD</em> Crohn’s disease, <em>IL-22</em> interleukin-22, <em>UMAP</em> uniform manifold approximation and projection, <em>UC</em> ulcerative colitis.</p></figcaption></figure><p id="Par31">Among patients with UC, three clusters were identified in the IL-22 all cohort (Fig. <a href="#Fig3" class="usa-link">3</a>B). The first cluster consisted of 100% of patients in remission, the second consisted of mostly patients in remission and mild disease, and the third consisted of a combination of patients with mild (26.9%), moderate (51.3%), and severe (18.5%) disease activity (Table S4, Online Resource 1). Similar clusters were seen in patients with high IL-22 (Fig. <a href="#Fig3" class="usa-link">3</a>B, Table S4, Online Resource 1). In patients with low IL-22, however, there were only two clusters consisting mostly of patients in remission and another of patients in remission and mild disease activity (Fig. <a href="#Fig3" class="usa-link">3</a>B, Table S4, Online Resource 1). Median age, disease duration, and treatment varied across clusters.</p></section><section id="Sec15"><h3 class="pmc_sec_title">Association model</h3>
<p id="Par33">IL-22 concentrations were found to be associated with disease activity when comparing ORs for risk of moderate/severe disease activity or mild disease activity using a multinomial logit model. The risk of moderate/severe disease activity versus remission was 2 times higher in patients with CD (OR: 2.02; 95% confidence interval [CI]: 1.52, 2.69) and 2.7 times higher in patients with UC (OR: 2.71; 95% CI: 1.70, 4.32) among those with high IL-22 concentrations versus those with low IL-22 concentrations (Fig. <a href="#Fig4" class="usa-link">4</a>). The ORs (95% CI) for risk of mild disease versus remission for patients with high IL-22 versus low IL-22 were 1.30 (0.98, 1.72) for CD and 1.66 (1.12, 2.46) for UC.</p>
<figure class="fig xbox font-sm" id="Fig4"><h4 class="obj_head">Fig. 4.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12365130_41598_2025_1939_Fig4_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2f0/12365130/3aba380a69dc/41598_2025_1939_Fig4_HTML.jpg" loading="lazy" id="d33e1555" height="255" width="706" alt="Fig. 4"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Odds ratios for disease activity among patients with high IL-22 vs. low IL-22. Based on a multinomial logit model adjusted for age, sex, disease duration, comorbidities (any/none), and main treatment classes (aminosalicylates, immunomodulators, anti-TNFα, anti-integrins, ustekinumab, corticosteroids). An OR of 1 indicates no difference between IL-22 high and low groups. An OR &gt; 1 indicates greater risk in the IL-22 high group relative to the IL-22 low group. <em>CD</em> Crohn’s disease, <em>C</em>I confidence interval, <em>IL-22</em> interleukin-22, <em>OR</em> odds ratio, <em>TNF</em> tumor necrosis factor, <em>UC</em> ulcerative colitis.</p></figcaption></figure></section><section id="Sec16"><h3 class="pmc_sec_title">XGBoost and SHAP value analysis</h3>
<p id="Par35">XGBoost was implemented to learn how to classify patients’ IL-22 concentration into low or high based on available features. The XGBoost model performance in the test set was evaluated with ROC-AUC. ROC-AUC was 0.63 for the CD cohort and 0.62 for the UC cohort. Based on subsequent SHAP analysis, sCDAI, IL-17A, and biologic therapy (anti-TNFα) were the 3 most relevant features for predicting IL-22 concentration (Fig. <a href="#Fig5" class="usa-link">5</a>A). Directional assessment revealed that higher sCDAI and IL-17A, as well as a prescription for biologic therapy (anti-TNFα), were predictive of high IL-22 in patients with CD (Fig. <a href="#Fig5" class="usa-link">5</a>A). In patients with UC, the 3 most relevant features for predicting IL-22 concentration were biologic therapy (anti-TNFα), 6-point UCDAI score, and disease activity (Fig. <a href="#Fig5" class="usa-link">5</a>B). When introducing directional assessment of SHAP values, there was a clear higher likelihood of predicting high IL-22 concentration when a patient had a prescription for biologic therapy (anti-TNFα), a high 6-point UCDAI score, or greater disease activity (Fig. <a href="#Fig5" class="usa-link">5</a>B). Patient-level data showing an example of SHAP value analysis to provide local (per-patient) interpretability is shown in Figure S2, Online Resource 1.</p>
<figure class="fig xbox font-sm" id="Fig5"><h4 class="obj_head">Fig. 5.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12365130_41598_2025_1939_Fig5_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2f0/12365130/5e6da4c73d59/41598_2025_1939_Fig5_HTML.jpg" loading="lazy" id="d33e1625" height="845" width="752" alt="Fig. 5"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig5/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Relevance of features predictive of IL-22 concentration based on SHAP values. (<strong>A</strong>) CD. (<strong>B</strong>) UC. The left-hand graph provides a general assessment of feature (variable) importance for the model to generate a prediction on IL-22 concentration level. The higher the SHAP value, the higher the contribution of a feature toward predicting the label. Thus, the most influential features are presented at the top. The right-hand graph provides additional detail by showing the directional impact of each feature. Each data point corresponds to 1 patient and is color-coded based on the value of the feature: red indicates high values for a given feature (e.g., a high sCDAI score), blue indicates low values (e.g., a low sCDAI score), and gray indicates a missing value (e.g., no recorded sCDAI score). The y-axis lists the features in order of importance, and the x-axis shows the magnitude of the SHAP value, indicating the extent to which each feature influences the model’s prediction. The greater the magnitude of the SHAP value – whether positive or negative – the stronger the impact of that feature on the prediction. A positive SHAP value for a data point indicates that the feature pushes the prediction toward the high IL-22 concentration label (category), while a negative SHAP value for a data point pushes it toward the low IL-22 concentration label. <sup>a</sup>Included the categories “absence of symptoms,” “rarely active,” “sometimes active,” “occasionally active,” “often active,” and “constantly active.” <em>CD</em> Crohn’s disease, <em>FCP</em> fecal calprotectin, <em>IBD</em> inflammatory bowel disease, <em>IFN</em> interferon, <em>IL</em> interleukin, <em>PGA</em> physician’s general assessment, <em>sCDAI</em> short Crohn’s disease activity index, <em>SES</em> simple endoscopic score, <em>TNF</em> tumor necrosis factor, <em>UC</em> ulcerative colitis, <em>UCDAI</em> ulcerative colitis disease activity index.</p></figcaption></figure></section></section><section id="Sec17"><h2 class="pmc_sec_title">Discussion</h2>
<p id="Par37">This is the first study to analyze plasma IL-22 samples in a large population of real-world patients with IBD with detailed clinical characterization. Plasma IL-22 concentrations were broadly similar in patients with CD and UC, with low concentrations more commonly observed in patients in remission, and higher levels observed in patients with moderate or severe disease activity. In an unsupervised cluster analysis, three clusters were observed based on disease activity for both CD and UC: a cluster with mixed moderate/high disease activity patients, a cluster with mixed mild/remission disease activity patients, and a cluster with patients in remission. Cohorts with high concentrations of plasma IL-22 clustered according to disease activity, while in the cohort with low concentrations of plasma IL-22, disease activity did not differentiate between clusters. Overall, the results of the cluster analysis indicated that disease activity was a major differentiating factor in patients overall and among those with high IL-22.</p>
<p id="Par38">A multinomial logit model confirmed the association between greater disease activity and higher IL-22 concentration, showing ≥ 2 times greater odds of moderate/severe disease versus remission with high concentrations of plasma IL-22 versus low IL-22 concentrations for both CD and UC. A similar pattern was seen for mild disease, with greater odds of mild disease versus remission among those with high IL-22 versus low IL-22. Our results are in agreement with an earlier observational analysis of blood and intestinal biopsies from the Mount Sinai Crohn’s and Colitis registry of ~ 1200 patients with IBD and transcriptomic data from 7 other smaller independent IBD datasets. This study identified a circulating molecular inflammation score that correlated with disease activity and showed a high level of similarity between CD and UC<sup><a href="#CR25" class="usa-link" aria-describedby="CR25">25</a></sup>. Based on our results, IL-22 may be one factor that makes up this molecular signature.</p>
<p id="Par39">Machine learning has been recognized as a tool that has the potential to aid clinicians in clinical practice by helping to determine diagnoses, inform treatment decisions, and predict patient prognosis<sup><a href="#CR26" class="usa-link" aria-describedby="CR26">26</a></sup>. Machine learning can also help clinicians to better understand complex data. This study introduced SHAP values to provide interpretability to the results obtained by a novel machine learning-based approach. Thus, we identify and explain how factors are associated with high or low plasma IL-22 concentration, which has not yet been reported in IBD. In agreement with the findings of the previous analyses, greater disease activity (as measured by sCDAI and 6-point UCDAI score) was shown to be an important predictor of high IL-22 plasma concentrations for CD and UC, as indicated by the high SHAP values in patients with high sCDAI/UCDAI scores. There were some similarities in features most strongly predicting high IL-22 plasma concentrations observed between CD and UC. Notably, 3 of the top 4 predictors of high IL-22 concentrations were the same for CD and UC: prescription of biologics (anti-TNFα) therapy, greater daily disease activity, and higher plasma concentrations of IL-17A. The prescription of anti-TNFα therapy and higher IL-17A levels are associated with increased severity of disease, which may explain this association; anti-TNFα therapy is reserved for patients with more active disease that have not responded to conventional immunomodulatory therapy<sup><a href="#CR27" class="usa-link" aria-describedby="CR27">27</a></sup>, and IL-17 is a proinflammatory cytokine secreted by the same family of immune cells as IL-22, including Th17 cells and group 3 innate lymphoid cells, with its production similarly induced by IL-23<sup><a href="#CR28" class="usa-link" aria-describedby="CR28">28</a></sup>. The moderate discriminating power of the model (ROC-AUC = 0.6) suggests a fair ability to distinguish between high and low IL-22. However, this may still limit well-grounded explanations of additional features.</p>
<p id="Par40">Current IBD biomarkers such as C-reactive protein (CRP) may present limitations in terms of sensitivity or specificity<sup><a href="#CR29" class="usa-link" aria-describedby="CR29">29</a></sup>. Approximately 55% of patients with mild UC and 10–20% with moderate to severe UC can have a CRP value within the normal range<sup><a href="#CR30" class="usa-link" aria-describedby="CR30">30</a></sup>. Thus, the use of additional biomarkers such as IL-22 or existing clinical markers such as fecal calprotectin (FCP) may help to provide a more complete picture. Our study suggests there is potential to incorporate use of IL-22 in IBD monitoring. Further study is needed to fully understand how IL-22 relates to IBD disease severity and how its use as a biomarker may be implemented in clinical practice. Assessment of differences between CD and UC, subgroup analyses by prior treatment type, and longitudinal analyses to assess the relationship between IL-22 and disease progression may be areas for future analysis.</p>
<section id="Sec18"><h3 class="pmc_sec_title">Limitations</h3>
<p id="Par41">As these data come from a real-world registry, not every patient will have a measurement for every variable. The number of missing values was high for some variables, such as FCP and CRP. Furthermore, the generalizability of the SPARC IBD CD and UC cohorts may be compromised by the lack of representativeness across patient racial and ethnicity groups in the US, and potentially also by disease severity, as most patients were mild or in remission status. Due to the high proportion of plasma IL-22 concentrations below the LLOQ, the discriminating power of the XGBoost classification task in these cohorts was biased toward low IL-22. Although we could not assess the generalizability of the trained XGBoost model because of the limited amount of data, we tried to mitigate this by tuning regularization hyperparameters, which helps to improve the model’s ability to make predictions on new, unseen patients.</p></section></section><section id="Sec19"><h2 class="pmc_sec_title">Conclusion</h2>
<p id="Par42">This is one of the largest studies evaluating the distribution of plasma IL-22 concentrations in a real-world population of patients with CD and UC with granular phenotypic data. Across multiple assessments, a consistent association was found between more severe disease activity and high concentrations of IL-22 in the plasma in patients with CD and UC. These data indicate that high concentrations of circulating IL-22 are related to severe IBD, and are consistent with IL-22 being a suitable biomarker for IBD disease activity.</p></section><section id="Sec20"><h2 class="pmc_sec_title">Electronic supplementary material</h2>
<p>Below is the link to the electronic supplementary material.</p>
<section class="sm xbox font-sm" id="MOESM1"><div class="media p"><div class="caption">
<a href="/articles/instance/12365130/bin/41598_2025_1939_MOESM1_ESM.pdf" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Material 1</a><sup> (265.6KB, pdf) </sup>
</div></div></section></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgements</h2>
<p>Writing assistance was provided by Rebecca Lane, PhD, and Kristin Carlin, BSPharm, of Peloton Advantage, an OPEN Health company, and funded by AstraZeneca.</p></section><section id="notes1"><h2 class="pmc_sec_title">Author contributions</h2>
<p>Study design: CC, NP, UG. Data analysis/interpretation: MO, DF, CS, JN, CC. Critical revision and review of the manuscript: All authors. Project/data management: CC, TF, JN, UG. Statistical analyses: MO, DF. Approval of final draft for submission: All authors.</p></section><section id="notes2"><h2 class="pmc_sec_title">Data availability</h2>
<p>The SPARC IBD data are available upon approved application to Crohn’s &amp; Colitis Foundation IBD Plexus (https://www.crohnscolitisfoundation.org/ibd-plexus).</p></section><section id="notes3"><h2 class="pmc_sec_title">Declarations</h2>
<section id="FPar1"><h3 class="pmc_sec_title">Competing interests</h3>
<p id="Par43">EK, JC, JN, MO, and CC: Employees and stock shareholders of AstraZeneca. DFL, EAD, and UG: Former employees of AstraZeneca. CS: Employee of the Kubrick Group, which was contracted by AstraZeneca to perform these analyses. TF: Employee of the Crohn’s &amp; Colitis Foundation. NP: Speaker, advisory consultant and/or research grants from AbbVie, Allergan, AstraZeneca, Bristol Myers Squibb, Celgene, Celltrion, Dr Falk Pharma UK Ltd, Ferring, Galapagos, Janssen, Roche, Pfizer, Sobi, Takeda, Tillotts, and Vifor.</p></section><section id="FPar2"><h3 class="pmc_sec_title">Ethics approval</h3>
<p id="Par430">This is a cross-sectional study of patients in the SPARC IBD cohort from the IBD Plexus registry of the Crohn’s &amp; Colitis Foundation. This study used patient data entered in SPARC IBD from initiation in 2016 to January 2022. The use of SPARC IBD and blood plasma samples for this study was approved by the Crohn’s &amp; Colitis Foundation in 2021.</p></section><section id="FPar3"><h3 class="pmc_sec_title">Consent to participate</h3>
<p id="Par439">All patients enrolled in the study provided informed consent to participate through a universal consent form authorizing use of their personal information for future IBD studies.</p></section></section><section id="fn-group1" class="fn-group"><h2 class="pmc_sec_title">Footnotes</h2>
<div class="fn-group p font-secondary-light font-sm"><div class="fn p" id="fn1">
<p><strong>Publisher’s note</strong></p>
<p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</div></div></section><section id="Bib1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="Bib1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="CR1">
<span class="label">1.</span><cite>Nowakowski, J., Chrobak, A. A. &amp; Dudek, D. Psychiatric illnesses in inflammatory bowel diseases - psychiatric comorbidity and biological underpinnings. <em>Psychiatr. Pol.</em><strong>50</strong>, 1157–1166 (2016).
</cite> [<a href="https://doi.org/10.12740/PP/62382" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28211554/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Nowakowski,%20J.,%20Chrobak,%20A.%20A.%20&amp;%20Dudek,%20D.%20Psychiatric%20illnesses%20in%20inflammatory%20bowel%20diseases%20-%20psychiatric%20comorbidity%20and%20biological%20underpinnings.%20Psychiatr.%20Pol.50,%201157%E2%80%931166%20(2016)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR2">
<span class="label">2.</span><cite>Panara, A. J. et al. The incidence and risk factors for developing depression after being diagnosed with inflammatory bowel disease: a cohort study. <em>Aliment. Pharmacol. Ther.</em><strong>39</strong>, 802–810 (2014).
</cite> [<a href="https://doi.org/10.1111/apt.12669" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24588323/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Panara,%20A.%20J.%20et%20al.%20The%20incidence%20and%20risk%20factors%20for%20developing%20depression%20after%20being%20diagnosed%20with%20inflammatory%20bowel%20disease:%20a%20cohort%20study.%20Aliment.%20Pharmacol.%20Ther.39,%20802%E2%80%93810%20(2014)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR3">
<span class="label">3.</span><cite>Mikocka-Walus, A., Knowles, S. R., Keefer, L. &amp; Graff, L. Controversies revisited: a systematic review of the comorbidity of depression and anxiety with inflammatory bowel diseases. <em>Inflamm. Bowel Dis.</em><strong>22</strong>, 752–762 (2016).
</cite> [<a href="https://doi.org/10.1097/MIB.0000000000000620" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26841224/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Mikocka-Walus,%20A.,%20Knowles,%20S.%20R.,%20Keefer,%20L.%20&amp;%20Graff,%20L.%20Controversies%20revisited:%20a%20systematic%20review%20of%20the%20comorbidity%20of%20depression%20and%20anxiety%20with%20inflammatory%20bowel%20diseases.%20Inflamm.%20Bowel%20Dis.22,%20752%E2%80%93762%20(2016)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR4">
<span class="label">4.</span><cite>van Gennep, S. et al. Impaired quality of working life in inflammatory bowel disease patients. <em>Dig. Dis. Sci.</em><strong>66</strong>, 2916–2924 (2021).
</cite> [<a href="https://doi.org/10.1007/s10620-020-06647-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8379106/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33063191/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?van%20Gennep,%20S.%20et%20al.%20Impaired%20quality%20of%20working%20life%20in%20inflammatory%20bowel%20disease%20patients.%20Dig.%20Dis.%20Sci.66,%202916%E2%80%932924%20(2021)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR5">
<span class="label">5.</span><cite>Le Berre, C., Ananthakrishnan, A. N., Danese, S., Singh, S. &amp; Peyrin-Biroulet, L. Ulcerative colitis and Crohn’s disease have similar burden and goals for treatment. <em>Clin. Gastroenterol. Hepatol.</em><strong>18</strong>, 14–23 (2020).
</cite> [<a href="https://doi.org/10.1016/j.cgh.2019.07.005" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31301452/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Le%20Berre,%20C.,%20Ananthakrishnan,%20A.%20N.,%20Danese,%20S.,%20Singh,%20S.%20&amp;%20Peyrin-Biroulet,%20L.%20Ulcerative%20colitis%20and%20Crohn%E2%80%99s%20disease%20have%20similar%20burden%20and%20goals%20for%20treatment.%20Clin.%20Gastroenterol.%20Hepatol.18,%2014%E2%80%9323%20(2020)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR6">
<span class="label">6.</span><cite>Petagna, L. et al. Pathophysiology of Crohn’s disease inflammation and recurrence. <em>Biol. Direct</em>. <strong>15</strong>, 23 (2020).
</cite> [<a href="https://doi.org/10.1186/s13062-020-00280-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7648997/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33160400/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Petagna,%20L.%20et%20al.%20Pathophysiology%20of%20Crohn%E2%80%99s%20disease%20inflammation%20and%20recurrence.%20Biol.%20Direct.%2015,%2023%20(2020)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR7">
<span class="label">7.</span><cite>Porter, R. J., Kalla, R. &amp; Ho, G. T. Ulcerative colitis: recent advances in the Understanding of disease pathogenesis. <em>F1000Research</em><strong>9</strong>, 294 (2020).</cite> [<a href="https://doi.org/10.12688/f1000research.20805.1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7194476/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32399194/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Porter,%20R.%20J.,%20Kalla,%20R.%20&amp;%20Ho,%20G.%20T.%20Ulcerative%20colitis:%20recent%20advances%20in%20the%20Understanding%20of%20disease%20pathogenesis.%20F1000Research9,%20294%20(2020)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR8">
<span class="label">8.</span><cite>Holtta, V. et al. IL-23/IL-17 immunity as a hallmark of Crohn’s disease. <em>Inflamm. Bowel Dis.</em><strong>14</strong>, 1175–1184 (2008).
</cite> [<a href="https://doi.org/10.1002/ibd.20475" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18512248/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Holtta,%20V.%20et%20al.%20IL-23/IL-17%20immunity%20as%20a%20hallmark%20of%20Crohn%E2%80%99s%20disease.%20Inflamm.%20Bowel%20Dis.14,%201175%E2%80%931184%20(2008)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR9">
<span class="label">9.</span><cite>Geremia, A. et al. IL-23-responsive innate lymphoid cells are increased in inflammatory bowel disease. <em>J. Exp. Med.</em><strong>208</strong>, 1127–1133 (2011).
</cite> [<a href="https://doi.org/10.1084/jem.20101712" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3173242/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21576383/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Geremia,%20A.%20et%20al.%20IL-23-responsive%20innate%20lymphoid%20cells%20are%20increased%20in%20inflammatory%20bowel%20disease.%20J.%20Exp.%20Med.208,%201127%E2%80%931133%20(2011)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR10">
<span class="label">10.</span><cite>Croxford, A. L., Mair, F. &amp; Becher, B. IL-23: one cytokine in control of autoimmunity. <em>Eur. J. Immunol.</em><strong>42</strong>, 2263–2273 (2012).
</cite> [<a href="https://doi.org/10.1002/eji.201242598" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22949325/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Croxford,%20A.%20L.,%20Mair,%20F.%20&amp;%20Becher,%20B.%20IL-23:%20one%20cytokine%20in%20control%20of%20autoimmunity.%20Eur.%20J.%20Immunol.42,%202263%E2%80%932273%20(2012)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR11">
<span class="label">11.</span><cite>Feagan, B. G. et al. Induction therapy with the selective interleukin-23 inhibitor Risankizumab in patients with moderate-to-severe Crohn’s disease: a randomised, double-blind, placebo-controlled phase 2 study. <em>Lancet</em><strong>389</strong>, 1699–1709 (2017).
</cite> [<a href="https://doi.org/10.1016/S0140-6736(17)30570-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28411872/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Feagan,%20B.%20G.%20et%20al.%20Induction%20therapy%20with%20the%20selective%20interleukin-23%20inhibitor%20Risankizumab%20in%20patients%20with%20moderate-to-severe%20Crohn%E2%80%99s%20disease:%20a%20randomised,%20double-blind,%20placebo-controlled%20phase%202%20study.%20Lancet389,%201699%E2%80%931709%20(2017)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR12">
<span class="label">12.</span><cite>Schmechel, S. et al. Linking genetic susceptibility to Crohn’s disease with Th17 cell function: IL-22 serum levels are increased in Crohn’s disease and correlate with disease activity and IL23R genotype status. <em>Inflamm. Bowel Dis.</em><strong>14</strong>, 204–212 (2008).
</cite> [<a href="https://doi.org/10.1002/ibd.20315" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18022867/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Schmechel,%20S.%20et%20al.%20Linking%20genetic%20susceptibility%20to%20Crohn%E2%80%99s%20disease%20with%20Th17%20cell%20function:%20IL-22%20serum%20levels%20are%20increased%20in%20Crohn%E2%80%99s%20disease%20and%20correlate%20with%20disease%20activity%20and%20IL23R%20genotype%20status.%20Inflamm.%20Bowel%20Dis.14,%20204%E2%80%93212%20(2008)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR13">
<span class="label">13.</span><cite>Pavlidis, P. et al. Interleukin-22 regulates neutrophil recruitment in ulcerative colitis and is associated with resistance to ustekinumab therapy. <em>Nat. Comm.</em><strong>13</strong>, 5820 (2022).</cite> [<a href="https://doi.org/10.1038/s41467-022-33331-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9530232/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36192482/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Pavlidis,%20P.%20et%20al.%20Interleukin-22%20regulates%20neutrophil%20recruitment%20in%20ulcerative%20colitis%20and%20is%20associated%20with%20resistance%20to%20ustekinumab%20therapy.%20Nat.%20Comm.13,%205820%20(2022)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR14">
<span class="label">14.</span><cite>Keir, M., Yi, Y., Lu, T. &amp; Ghilardi, N. The role of IL-22 in intestinal health and disease. <em>J. Exp. Med.</em><strong>217</strong>, e20192195 (2020).
</cite> [<a href="https://doi.org/10.1084/jem.20192195" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7062536/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32997932/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Keir,%20M.,%20Yi,%20Y.,%20Lu,%20T.%20&amp;%20Ghilardi,%20N.%20The%20role%20of%20IL-22%20in%20intestinal%20health%20and%20disease.%20J.%20Exp.%20Med.217,%20e20192195%20(2020)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR15">
<span class="label">15.</span><cite>Andoh, A. et al. Interleukin-22, a member of the IL-10 subfamily, induces inflammatory responses in colonic subepithelial myofibroblasts. <em>Gastroenterology</em><strong>129</strong>, 969–984 (2005).
</cite> [<a href="https://doi.org/10.1053/j.gastro.2005.06.071" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16143135/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Andoh,%20A.%20et%20al.%20Interleukin-22,%20a%20member%20of%20the%20IL-10%20subfamily,%20induces%20inflammatory%20responses%20in%20colonic%20subepithelial%20myofibroblasts.%20Gastroenterology129,%20969%E2%80%93984%20(2005)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR16">
<span class="label">16.</span><cite>Zhao, N. et al. Role of Interleukin-22 in ulcerative colitis. <em>Biomed. Pharmacother</em>. <strong>159</strong>, 114273 (2023).
</cite> [<a href="https://doi.org/10.1016/j.biopha.2023.114273" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36696801/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhao,%20N.%20et%20al.%20Role%20of%20Interleukin-22%20in%20ulcerative%20colitis.%20Biomed.%20Pharmacother.%20159,%20114273%20(2023)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR17">
<span class="label">17.</span><cite>Wei, H. X., Wang, B. &amp; Li, B. IL-10 and IL-22 in mucosal immunity: driving protection and pathology. <em>Front. Immunol.</em><strong>11</strong>, 1315 (2020).
</cite> [<a href="https://doi.org/10.3389/fimmu.2020.01315" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7332769/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32670290/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wei,%20H.%20X.,%20Wang,%20B.%20&amp;%20Li,%20B.%20IL-10%20and%20IL-22%20in%20mucosal%20immunity:%20driving%20protection%20and%20pathology.%20Front.%20Immunol.11,%201315%20(2020)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR18">
<span class="label">18.</span><cite>Powell, N. et al. Interleukin-22 orchestrates a pathological Endoplasmic reticulum stress response transcriptional programme in colonic epithelial cells. <em>Gut</em><strong>69</strong>, 578–590 (2020).
</cite> [<a href="https://doi.org/10.1136/gutjnl-2019-318483" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7034350/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31792136/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Powell,%20N.%20et%20al.%20Interleukin-22%20orchestrates%20a%20pathological%20Endoplasmic%20reticulum%20stress%20response%20transcriptional%20programme%20in%20colonic%20epithelial%20cells.%20Gut69,%20578%E2%80%93590%20(2020)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR19">
<span class="label">19.</span><cite>Brand, S. et al. IL-22 is increased in active Crohn’s disease and promotes Proinflammatory gene expression and intestinal epithelial cell migration. <em>Am. J. Physiol. Gastrointest. Liver Physiol.</em><strong>290</strong>, G827–838 (2006).
</cite> [<a href="https://doi.org/10.1152/ajpgi.00513.2005" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16537974/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Brand,%20S.%20et%20al.%20IL-22%20is%20increased%20in%20active%20Crohn%E2%80%99s%20disease%20and%20promotes%20Proinflammatory%20gene%20expression%20and%20intestinal%20epithelial%20cell%20migration.%20Am.%20J.%20Physiol.%20Gastrointest.%20Liver%20Physiol.290,%20G827%E2%80%93838%20(2006)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR20">
<span class="label">20.</span><cite>Yu, L. Z. et al. Expression of interleukin-22/STAT3 signaling pathway in ulcerative colitis and related carcinogenesis. <em>World J. Gastroenterol.</em><strong>19</strong>, 2638–2649 (2013).
</cite> [<a href="https://doi.org/10.3748/wjg.v19.i17.2638" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3645382/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23674871/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Yu,%20L.%20Z.%20et%20al.%20Expression%20of%20interleukin-22/STAT3%20signaling%20pathway%20in%20ulcerative%20colitis%20and%20related%20carcinogenesis.%20World%20J.%20Gastroenterol.19,%202638%E2%80%932649%20(2013)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR21">
<span class="label">21.</span><cite>Sands, B. E. et al. Efficacy and safety of MEDI2070, an antibody against Interleukin 23, in patients with moderate to severe Crohn’s disease: a phase 2a study. <em>Gastroenterology</em><strong>153</strong>, 77–86e76 (2017).
</cite> [<a href="https://doi.org/10.1053/j.gastro.2017.03.049" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28390867/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Sands,%20B.%20E.%20et%20al.%20Efficacy%20and%20safety%20of%20MEDI2070,%20an%20antibody%20against%20Interleukin%2023,%20in%20patients%20with%20moderate%20to%20severe%20Crohn%E2%80%99s%20disease:%20a%20phase%202a%20study.%20Gastroenterology153,%2077%E2%80%9386e76%20(2017)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR22">
<span class="label">22.</span><cite>Raffals, L. E. et al. The development and initial findings of a study of a prospective adult research cohort with inflammatory bowel disease (SPARC IBD). <em>Inflamm. Bowel Dis.</em><strong>28</strong>, 192–199 (2022).
</cite> [<a href="https://doi.org/10.1093/ibd/izab071" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9013198/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34436563/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Raffals,%20L.%20E.%20et%20al.%20The%20development%20and%20initial%20findings%20of%20a%20study%20of%20a%20prospective%20adult%20research%20cohort%20with%20inflammatory%20bowel%20disease%20(SPARC%20IBD).%20Inflamm.%20Bowel%20Dis.28,%20192%E2%80%93199%20(2022)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR23">
<span class="label">23.</span><cite>Chen, T., Guestrin, C. &amp; XGBoost: A Scalable Tree Boosting System.<em> Proceedings of the 22nd ACM SIGKDD International Conference on Knowledge Discovery and Data Mining. City; Association for Computing Machinery</em>. 785–794. (2016).</cite>
</li>
<li id="CR24">
<span class="label">24.</span><cite>Curran Associates Inc., International Conference on Neural Information Processing Systems. A unified approach to interpreting model predictions. <a href="https://arxiv.org/abs/1705.07874" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://arxiv.org/abs/1705.07874</a>. (Accessed 27 Sep 2023). (2017).</cite>
</li>
<li id="CR25">
<span class="label">25.</span><cite>Argmann, C. et al. Biopsy and blood-based molecular biomarker of inflammation in IBD. <em>Gut</em><strong>72</strong>, 1271–1287 (2023).
</cite> [<a href="https://doi.org/10.1136/gutjnl-2021-326451" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10014487/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36109152/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Argmann,%20C.%20et%20al.%20Biopsy%20and%20blood-based%20molecular%20biomarker%20of%20inflammation%20in%20IBD.%20Gut72,%201271%E2%80%931287%20(2023)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR26">
<span class="label">26.</span><cite>Rajkomar, A., Dean, J. &amp; Kohane, I. Machine learning in medicine. <em>N. Engl. J. Med.</em><strong>380</strong>, 1347–1358 (2019).
</cite> [<a href="https://doi.org/10.1056/NEJMra1814259" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30943338/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Rajkomar,%20A.,%20Dean,%20J.%20&amp;%20Kohane,%20I.%20Machine%20learning%20in%20medicine.%20N.%20Engl.%20J.%20Med.380,%201347%E2%80%931358%20(2019)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR27">
<span class="label">27.</span><cite>Lamb, C. A. et al. British society of gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. <em>Gut</em><strong>68</strong>, s1–s106 (2019).
</cite> [<a href="https://doi.org/10.1136/gutjnl-2019-318484" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6872448/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31562236/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lamb,%20C.%20A.%20et%20al.%20British%20society%20of%20gastroenterology%20consensus%20guidelines%20on%20the%20management%20of%20inflammatory%20bowel%20disease%20in%20adults.%20Gut68,%20s1%E2%80%93s106%20(2019)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR28">
<span class="label">28.</span><cite>Aggarwal, S., Ghilardi, N., Xie, M. H., de Sauvage, F. J. &amp; Gurney, A. L. Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. <em>J. Biol. Chem.</em><strong>278</strong>, 1910–1914 (2003).
</cite> [<a href="https://doi.org/10.1074/jbc.M207577200" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12417590/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Aggarwal,%20S.,%20Ghilardi,%20N.,%20Xie,%20M.%20H.,%20de%20Sauvage,%20F.%20J.%20&amp;%20Gurney,%20A.%20L.%20Interleukin-23%20promotes%20a%20distinct%20CD4%20T%20cell%20activation%20state%20characterized%20by%20the%20production%20of%20interleukin-17.%20J.%20Biol.%20Chem.278,%201910%E2%80%931914%20(2003)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR29">
<span class="label">29.</span><cite>Mosli, M. H. et al. C-reactive protein, fecal calprotectin, and stool lactoferrin for detection of endoscopic activity in symptomatic inflammatory bowel disease patients: A systematic review and meta-analysis. <em>Am. J. Gastroenterol.</em><strong>110</strong>, 802–819 (2015).
</cite> [<a href="https://doi.org/10.1038/ajg.2015.120" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25964225/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Mosli,%20M.%20H.%20et%20al.%20C-reactive%20protein,%20fecal%20calprotectin,%20and%20stool%20lactoferrin%20for%20detection%20of%20endoscopic%20activity%20in%20symptomatic%20inflammatory%20bowel%20disease%20patients:%20A%20systematic%20review%20and%20meta-analysis.%20Am.%20J.%20Gastroenterol.110,%20802%E2%80%93819%20(2015)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR30">
<span class="label">30.</span><cite>Turner, D. et al. C-reactive protein (CRP), erythrocyte sedimentation rate (ESR) or both? A systematic evaluation in pediatric ulcerative colitis. <em>J. Crohns Colitis</em>. <strong>5</strong>, 423–429 (2011).
</cite> [<a href="https://doi.org/10.1016/j.crohns.2011.05.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21939916/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Turner,%20D.%20et%20al.%20C-reactive%20protein%20(CRP),%20erythrocyte%20sedimentation%20rate%20(ESR)%20or%20both?%20A%20systematic%20evaluation%20in%20pediatric%20ulcerative%20colitis.%20J.%20Crohns%20Colitis.%205,%20423%E2%80%93429%20(2011)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12365130/bin/41598_2025_1939_MOESM1_ESM.pdf" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Material 1</a><sup> (265.6KB, pdf) </sup>
</div></div></section></section><section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>The SPARC IBD data are available upon approved application to Crohn’s &amp; Colitis Foundation IBD Plexus (https://www.crohnscolitisfoundation.org/ibd-plexus).</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Scientific Reports are provided here courtesy of <strong>Nature Publishing Group</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1038/s41598-025-01939-7"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/41598_2025_Article_1939.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (1.9 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12365130/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12365130/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12365130%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12365130/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12365130/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12365130/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40830140/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12365130/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40830140/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12365130/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12365130/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="KUFnoubpFlTj599M3jO0va3bAoG1k38eMjDtiK7zmKQ2sFC9oOvupJpMc26KxBiI">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
